RTW Biotech Opportunities Ltd RTWFF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 13.54M | 24.06M | 34.57M | 34.84M | 35.11M |
| Total Revenue | 13.54M | 24.06M | 34.57M | 34.84M | 35.11M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 13.54M | 24.06M | 34.57M | 34.84M | 35.11M |
| SG&A Expenses | 12.93M | 12.54M | 12.15M | 12.22M | 12.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.56M | 14.13M | 13.69M | 13.58M | 13.48M |
| Operating Income | -1.02M | 9.93M | 20.88M | 21.26M | 21.63M |
| Income Before Tax | 455.15M | 350.17M | 245.19M | 76.41M | -92.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 455.15 | 350.17 | 245.19 | 76.41 | -92.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 455.15M | 350.17M | 245.19M | 76.41M | -92.38M |
| EBIT | -1.02M | 9.93M | 20.88M | 21.26M | 21.63M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 1.40 | 1.08 | 0.75 | 0.24 | -0.28 |
| Normalized Basic EPS | 0.13 | 0.14 | 0.15 | 0.07 | -0.02 |
| EPS Diluted | 1.40 | 1.08 | 0.75 | 0.24 | -0.28 |
| Normalized Diluted EPS | 0.13 | 0.14 | 0.15 | 0.07 | -0.02 |
| Average Basic Shares Outstanding | 1.30B | 1.31B | 1.31B | 1.32B | 1.33B |
| Average Diluted Shares Outstanding | 1.30B | 1.31B | 1.31B | 1.32B | 1.33B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 3.10% | 2.01% | -- | -- | -- |